(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PROXYGEN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

PROXYGEN

ST13

US500000079327147

Class

1, 5, 42

Filing

79327147

Registration

6982513

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

26

Latest update

06/13/2023

Trademark type

Word

Nice classes

1, 5, 42

Filing date

10/22/2021

Registration date

02/21/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/21/2023

Last transaction

02/21/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

27

Owner location

AT

Examiner

KHOURI, SANI

Law office

M10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Proxygen GmbH

Representatives

Claudia W. Stangle Leydig, Voit & Mayer Ltd.

Technical classification

Nice Classes

Class 1Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemical preparations for scientific purposes; molecules for use in industryprotein-modulating molecules for use in the pharmaceutical industry; molecules for use in scienceprotein-modulating molecules for use in the pharmaceutical industry; molecules for molecular biologyother than for medical or veterinary useprotein-modulating molecules for use in the pharmaceutical industry

Class 5

Pharmaceutical and therapeutic preparations for the treatment of cancerimmunological diseasesinflammatory diseasesneurological diseasesgenetic disorders; pharmaceutical and therapeutic preparations for modulating protein degradation pathways

Class 42

Scientific research and development services; scientific research of protein degradation; discovery and development of protein degradation pathway modulating moleculesscientific research services; scientific research of protein ubiquitination; discovery and development of proximity-inducing agentsscientific research services; research and development of proteolysis targeting chimeras; research and development of ligase-mediated protein modifications; discovery and development of molecular glue degradersscientific research services; discovery and development of monovalent protein degradersscientific research services

Publications

History of USPTO decisions and trademark events.

26 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

06/13/2023

FICS

FINAL DISPOSITION NOTICE SENT TO IB

05/24/2023

FIMP

FINAL DISPOSITION PROCESSED

05/24/2023

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

05/21/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/21/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

02/21/2023

GPNX

NOTIFICATION PROCESSED BY IB

12/12/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/06/2022

PUBO

PUBLISHED FOR OPPOSITION

12/06/2022

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

11/23/2022

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

11/23/2022

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/18/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/16/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/02/2022

RFNT

REFUSAL PROCESSED BY IB

10/18/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/14/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/13/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/13/2022

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

09/29/2022

RFRR

REFUSAL PROCESSED BY MPU

09/29/2022

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

08/08/2022

CNRT

NON-FINAL ACTION WRITTEN

08/07/2022

DOCK

ASSIGNED TO EXAMINER

08/01/2022

MAFR

APPLICATION FILING RECEIPT MAILED

12/07/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/03/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

12/02/2021

Continuous trademark protection

Get notified about every new filing that threatens PROXYGEN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.